New combo therapy offers hope for advanced lung cancer patients
Disease control
Recruiting now
This study is for people with advanced non-small cell lung cancer (stage IIIB/C-IV) who cannot tolerate standard chemoradiation. It tests a treatment plan of platinum-based chemotherapy, followed by a special type of radiation and the immunotherapy drug Tislelizumab. The goal is …
Phase: PHASE2 • Sponsor: Zibo Municipal Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC